Skip to main content
letter
. 2025 Aug 18;15(9):8737–8741. doi: 10.21037/qims-24-2207

Figure 3.

Figure 3

Timeline of patient treatment. BRD, bortezomib, lenalidomide, and dexamethasone; CR, complete response; D-KPD, daratumumab-carfilzomib, pomalidomide, and dexamethasone; IRD, ixazomib, lenalidomide, and dexamethasone.